Abstract P1-15-21: The molecular characterisation of early and advanced breast cancer in a Middle-Eastern breast cancer cohort treated with neo/adjuvant anthracycline+/-taxane-base... by Dawood, S, Korbie, D, Pheasant, M, Kazim, H, Al Hamadi, A, Lloyd, C, Dent, R, Mainwaring, PN

Get full text

Abstract P4-05-16: Quality metric study of real-time targeted massive parallel sequencing (MPS) (ampliseq comprehensive cancer panel (CCP)) and bioinformatics in early breast cance... by Mainwaring, PN, Pyke, C, Korbie, D, Pheasant, M, O'Neill, K, Musgrave, K, Phillips, C, Francis, G, Trau, M

Get full text

The immune response to breast cancer, and the case for DC immunotherapy by Allan, C.P., Turtle, C.J., Mainwaring, P.N., Pyke, C., Hart, D.N.J.

Get full text

Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer by Mainwaring, P N, Ellis, P A, Detre, S, Smith, I E, Dowsett, M

Get full text

Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy by Mainwaring, PN, Nicolson, MC, Hickish, T, Penson, R, Joel, S, Slevin, M, Smith, IE

Get full text

Oral Idarubicin as a Single Agent Therapy in Patients with Relapsed or Resistant Multiple Myeloma by Sumpter, Kate, Powles, Ray L, Raje, Noopur, Ramiah, Veshana, Kulkarni, Samar, Treleaven, Jennie, Mainwaring, Paul N

Get full text

Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma by Mainwaring, P.N., Atkinson, H., Chang, J., Moore, J., Hancock, B.W., Guillou, P.J., Oskam, R., Gore, M.E.

Get full text

Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron by Childs, A. M., Coates, A. S., Cox, K. M., Mainwaring, P. N.

Get full text